Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
ISRIB (trans-isomer): Unlocking Next-Generation Control o...
2025-09-26
Explore how ISRIB (trans-isomer), a leading integrated stress response inhibitor, enables mechanistic dissection of cellular stress adaptation and offers unprecedented insights for liver fibrosis and neurodegenerative disease models. This article delivers a unique, systems-level perspective distinct from existing ISRIB content.
-
3X (DYKDDDDK) Peptide: Next-Generation Epitope Ta
2025-09-25
Discover how the 3X (DYKDDDDK) Peptide revolutionizes cotranslational protein modification, enabling advanced affinity purification and immunodetection of FLAG fusion proteins. This in-depth analysis reveals unique insights into ribosome-associated processing and metal-dependent ELISA applications.
-
Panobinostat (LBH589): Bridging Epigenetic HDAC Inhibitio...
2025-09-24
Explore how Panobinostat (LBH589), a broad-spectrum hydroxamic acid-based histone deacetylase inhibitor, uniquely converges epigenetic modulation with cutting-edge apoptotic pathways. This article highlights new mechanistic insights and advanced applications in cancer and resistance research.
-
Filipin III: A Precision Tool for Membrane Cholesterol Vi...
2025-09-23
Explore how Filipin III, a cholesterol-binding fluorescent antibiotic, enables high-resolution membrane cholesterol visualization and advances understanding of cholesterol-related disease mechanisms. This article examines Filipin III’s unique biochemical properties and its application in dissecting cholesterol dynamics in metabolic liver disorders.
-
An important and well documented pathway involved in
2025-03-03

An important and well-documented pathway involved in cellular growth and proliferation is the mTOR-mediated synthesis of proteins and lipids [7,13,14]. Although found to be tissue specific or context specific regulation, it has always been observed that either one or both the mTOR complexes regulate
-
The synthetic adipoR agonists AdipoRon and are both
2025-03-03

The synthetic adipoR agonists, AdipoRon (1) and 112254 (2), are both detectable in human plasma [18]. However, with increasing knowledge about their metabolism [19], a method for detection from human urine is conceivable and would be preferred given the easier accessibility and greater frequency of
-
br Material and methods br Results br Discussion To develop
2025-03-03

Material and methods Results Discussion To develop a novel regenerative and/or neuroprotective therapy for optic neuropathy, including glaucoma, numerous studies have tested new candidates favorable to RGC survival and axon regeneration. Among the many candidate drugs, AdoR modulators are o
-
An alternative approach to the administration of ADO agonist
2025-03-03

An alternative approach to the administration of ADO agonists is to amplify the actions of endogenous ADO by inhibiting the ADO-metabolizing enzyme, ADO kinase (AK). Inhibition of AK has the net effect of potentiating the local concentration and the effects of ADO in the extracellular compartment. T
-
Synthesis pharmacological evaluation for the binding at
2025-03-03

Synthesis, pharmacological evaluation for the binding at hA, hA and hA ARs, and efficacy at hA subtype of the synthesized compounds, together with the assessment of their theoretical ADME properties were the guidelines in this preliminary drug discovery investigation. The synthetic pathways which y
-
Altogether the situations described above
2025-03-03

Altogether, the situations described above clearly impede the critical steps of drug discovery and development and the scientific process in general [14]. In conclusion, it is the opinion of these authors that many exciting lines of drug discovery (which includes those devoted to nAChR ligands) have
-
ACE inhibition is often thought to play
2025-03-03

ACE inhibition is often thought to play a central role in the mechanisms of blood pressure reduction in vivo, and most ACE inhibitory (ACEi) peptides were characterized based on in vitro ACE inhibition. A relationship between in vitro ACE inhibition and antihypertensive activity, however, is not app
-
br Methods br Results and discussion br Conclusions br Ackno
2025-03-03

Methods Results and discussion Conclusions Acknowledgements The authors thank Dr. Francois Alhenc-Gelas (then INSERM U367, Paris, France), who kindly provided the plasmid for truncated soluble recombinant human ACE – WTΔ, Dr. Elena Arablinskaya (Institute of Phtiziopulmonology, Moscow, R
-
hydroxydopamine OHDA is a selective
2025-03-03

6-hydroxydopamine (6-OHDA) is a selective catecholaminergic neurotoxin mainly used to generate lesions in the nigrostriatal pathway in rats (Ungerstedt, 1968). The most common use of 6-OHDA is via unilateral injection into the rat medial forebrain bundle (MFB). DA depletion, nigral DA cell loss, and
-
While it is known that circulating LDL C levels
2025-03-01

While it is known that circulating LDL-C levels are largely regulated by either controlling the rate of hepatic production of its triglyceride-rich precursor VLDL particle or the rate of LDLR-mediated LDL particle clearance [58], it should be noted that important differences exist between rodents an
-
Although several different membrane estrogen
2025-03-01

Although several different membrane estrogen receptors have been reported (Qiu et al., 2008; Revankar et al., 2005), a large percentage of membrane-initiated steroid hormone signaling appears to be performed by a subpopulation of the same receptors that act in the nucleus. Specifically, estrogen rec
16548 records 19/1104 page Previous Next First page 上5页 1617181920 下5页 Last page